GRA_Logo

 + Home + About Us + Contact Us
+ Drug Delivery   + Monitoring & Diagnostics   + Healthcare    + Therapeutics    + Wound Care
 
Patient Monitoring & Diagnostics


 Electronic Blood Pressure Monitors
The key enablers of the shift to hypertension self-monitoring are technological advances that provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Because of the associated morbidity and mortality and the cost to society, hypertension is an important public health challenge. .... more

 Patient Self-Monitoring
The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings. The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of ..... more

 Coagulation Self-Testing
For the millions of patients in the US and worldwide prescribed warfarin for oral anticoagulation therapy (OAT), the ability to monitor coagulation rates and adjust drug dosage to optimize therapeutic outcomes is a critical element of patient care. The availability of self-testing monitors provides patients with an opportunity to self-test and avoid frequent caregiver visits. Compared to blood glucose monitoring, OAT self-testing presents a higher level of complexity and risk, placing a.... more


 Patient Self-Monitoring
The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings. The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of ..... more

 Noninvasive Glucose Monitors
For diabetes patients, glucose monitoring is a way of life, a several-times-per-day routine critical to physiological health. But while the traditional finger prick method has been a standard disease management tool for decades, issues of patient compliance and the limitations of current methods in detecting short-term fluctuations in glucose levels have brought a host of companies ........more

 Continuous Glucose Monitors
The convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Continuous glucose monitors that are designed .......more

 Wireless In-Patient Monitors & Monitoring Systems
As the health care sector continues to search for ways to control expenses and improve patient quality-of-care, integrating the flow of patient information on a facility-wide basis has been viewed as an essential first-step in streamlining the management of patient care. Extending integration beyond the wired hospital LAN via ....more

 Molecular Imaging Agents
Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine. The ability of this new generation of........more

 Continuous Remote Cardiac Arrhythmia Monitors
The current thinking in mobile cardiac monitoring incorporates a design philosophy where patient comfort and independent operation are the focus. To this end, the new generation of ambulatory cardiac monitors is benefiting from the convergence of light-weight materials, short-range device-to-device communications technology and....more


 

 

Recent Research

Prefilled Syringes to 2016

Drug Self-Administration Markets to 2016

Therapeutic Proteins to 2016


Events

American Association for Clinical Chemistry (July 2012)

World Congress on Glucose Monitoring and Insulin Delivery (April 2012)

 
Greystone Research Associates
98 Route 101A, Suite 17
Amherst, NH 03031 USA

Phone: 603-595-4340/ Fax: 603-218-7020
Copyright 2011 ·  Greystone Research Associates  ·  All Rights Reserved · Conditions of Use  ·  Career